NEW PURIFIED VERO-CELL VACCINE PREVENTS RABIES IN PATIENTS BITTEN BY RABID ANIMALS
References (20)
- et al.
Rabies vaccines produced in cell culture
Ann Inst Pasteur/Virol
(1985) - et al.
Rabies vaccine produced in cell culture. production control and clinical results
- et al.
Post-exposure rabies prophylaxis: establishing effectiveness of abbreviated treatments
Vaccine
(1985) - et al.
Economical multicple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis
Lancet
(1985) - et al.
A new vaccine produced from rabies virus cultivated on vero cells
- et al.
Compatability and immunogenicity of Merieux's purified vero rabies vaccine (PVRV) in healthy subjects
- et al.
Purified vero call rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens
J Hyg Camb
(1986) - et al.
Study of the efficiency of a vaccine produced from rabies virus cultivated on vero cells
- et al.
The fluorescent antibody test
There are more references available in the full text version of this article.
Cited by (37)
Rabies Vaccines
2017, Plotkin's VaccinesRabies vaccines
2012, Vaccines: Sixth EditionThe role of vaccination in rabies prevention
2012, Current Opinion in VirologyCitation Excerpt :In the 1980s another second generation rabies vaccine was developed but this time on a continuous cell line. Vero cells were already being employed in the mass production of inactivated polio vaccines and in 1985 a Vero cell rabies vaccine produced using the PM strain was licensed in France [23]. Continuous cell lines offer the advantage of being able to scale up easily and do not lose their ability to divide after several passages as is the case with primary cell lines.
RABIES VIRUS
2009, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth EditionRabies vaccines
2008, Vaccines
Copyright © 1986 Published by Elsevier Ltd.